Explore more publications!
Cincinnati Wellness Review
Got News to Share?

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 6, 2026

GENFIT : Profil de sécurité favorable en Phase 1 et forte activité anti-inflammatoire pour G1090N, actif clé dans l’ACLF
January 6, 2026

GENFIT : Profil de sécurité favorable en Phase 1 et forte activité anti-inflammatoire pour G1090N, actif clé dans l’ACLF

Indeterminate GlobeNewswire
GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N  
January 6, 2026

GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N  

Indeterminate GlobeNewswire
Transparency Notification from Shareholders
January 6, 2026

Transparency Notification from Shareholders

Indeterminate GlobeNewswire
Clinical Neurology Specialists Partnering with Leading International Nonprofit to Accelerate Alzheimer’s Research in Las Vegas
January 6, 2026

Clinical Neurology Specialists Partnering with Leading International Nonprofit to Accelerate Alzheimer’s Research in Las Vegas

Indeterminate GlobeNewswire
Andrew Hillman Introduces Biotech Innovation Grant for Undergraduate Students
January 6, 2026

Andrew Hillman Introduces Biotech Innovation Grant for Undergraduate Students

Indeterminate GlobeNewswire
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)
January 6, 2026

A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)

Indeterminate GlobeNewswire
F45 Training names Joi + Blokes Official Diagnostics and Personalized Supplements Partner
January 6, 2026

F45 Training names Joi + Blokes Official Diagnostics and Personalized Supplements Partner

Indeterminate GlobeNewswire
Teclison, Inc. to Participate in ASCO Gastrointestinal Cancers Symposium
January 6, 2026

Teclison, Inc. to Participate in ASCO Gastrointestinal Cancers Symposium

Indeterminate GlobeNewswire
PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program
January 6, 2026

PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program

Indeterminate GlobeNewswire
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
January 6, 2026

Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV

Indeterminate GlobeNewswire
SoldierStrong Announces Annual SoldierScholar Recipients For 2025
January 6, 2026

SoldierStrong Announces Annual SoldierScholar Recipients For 2025

Indeterminate GlobeNewswire
Medtech Incubator Partners with Leap Distributors to Support U.S. Market Expansion Efforts
January 6, 2026

Medtech Incubator Partners with Leap Distributors to Support U.S. Market Expansion Efforts

Indeterminate GlobeNewswire
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
January 6, 2026

QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session

Indeterminate GlobeNewswire
Joint Commission Opens 2026 Award Applications to Recognize Excellence in Healthcare Quality and Patient Safety
January 6, 2026

Joint Commission Opens 2026 Award Applications to Recognize Excellence in Healthcare Quality and Patient Safety

Indeterminate GlobeNewswire
Methyl Acetate Market worth $388.5 million by 2030, at a CAGR of 7.9%, says MarketsandMarkets™
January 6, 2026

Methyl Acetate Market worth $388.5 million by 2030, at a CAGR of 7.9%, says MarketsandMarkets™

Indeterminate GlobeNewswire
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Olympia Pharmaceuticals Launches Rebranded Website, Ushering in a New Era of Seamless Navigation and Advanced Features
January 6, 2026

Olympia Pharmaceuticals Launches Rebranded Website, Ushering in a New Era of Seamless Navigation and Advanced Features

Indeterminate GlobeNewswire
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
January 6, 2026

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

Indeterminate GlobeNewswire
Day One Completes Acquisition of Mersana Therapeutics
January 6, 2026

Day One Completes Acquisition of Mersana Therapeutics

Indeterminate GlobeNewswire
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
January 6, 2026

Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions